Navigation Links
Gene Variant Raises Risk of Uterine Fibroids
Date:2/24/2009

Mutation discovered more common in white women, but different genes might raise risk in black women

TUESDAY, Feb. 24 (HealthDay News) -- Researchers have found a genetic marker that may indicate if a woman has a greater chance of developing uterine fibroids, a new study says.

Shorter, white women who test positive for the TC227 allele in their HMGA2 gene may be more likely to develop the muscular tumors in their uterus, according to a study of 248 pairs of sisters and their relatives. HMGA2 is linked to a person's height and the TC227 allele may be part of the gene.

"This genetic indicator could prove, after further investigations, to be valuable information for women making decisions about medical management of fibroids," senior study author Cynthia Morton, a director of cytogenetics at Brigham and Women's Hospital. "A woman with symptomatic fibroids might one day undergo diagnostic testing for the TC227 allele to determine whether she's genetically predisposed to develop additional fibroids."

The research appears online in Human Genetics.

Only white women were studied because the TC227 allele is much less common in black women.

"We believe that there are multiple genetic indicators for fibroids, in addition to the TC227 allele in white women, including genetic risk alleles for predisposition specific in black women who suffer an earlier age of onset and more severe fibroid symptoms," Morton said.

More information

The U.S. Department of Health and Human Services has more about uterine fibroids.



-- Kevin McKeever



SOURCE: Brigham and Women's Hospital, news release, February 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Gene Variant Tied to Severity of Drinking
2. Gene Variant Raises Risk for Brain Cancer at Young Age
3. Gene Variant May Hike Womens Risk of Alzheimers
4. Biologist finds plant polymerases IV and V are really variants of Polymerase II
5. Gene Variant Tied to Smokers Risk of Lung Cancer
6. Genetic Variants Tied to Obesity
7. NEW Line of Pushbutton Pill Cases Launched by Variant Products
8. Newly found gene variants account for kidney diseases among African-Americans
9. Genetic variants associated with vitamin B12
10. APA resolves to play leading role in improving treatment for gender-variant people
11. Gene Variant May Contribute to Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gene Variant Raises Risk of Uterine Fibroids
(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... Dallas, Texas (PRWEB) , ... May 04, 2016 , ... ... cancer awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging ... heed dermatology experts’ advice and focus on skin safety and health now and in ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals ... cellular and metabolic health. This synergistic combination of omega-3 fatty acids and potent ... 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
Breaking Medicine Technology: